Log In
Print
BCIQ
Print
Print this Print this
 

golvatinib (E7050)

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionVascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) and c-Met receptor tyrosine kinase inhibitor
Molecular Target Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2) ; c-Met receptor tyrosine kinase
Mechanism of ActionVascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) kinase inhibitor; c-Met receptor tyrosine kinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today